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Prognostic Markers in CAD

Coronary Calcium Independently
Predicts Incident Premature Coronary Heart
Disease Over Measured Cardiovascular Risk Factors
Mean Three-Year Outcomes in the
Prospective Army Coronary Calcium (PACC) Project
Allen J. Taylor, MD, Jody Bindeman, BSN, Irwin Feuerstein, MD, Felix Cao, MS, Michael Brazaitis, MD,
Patrick G. O’Malley, MD, MPH
Washington, DC
We sought to examine the independent predictive value of coronary artery calcium detection
for coronary outcomes in a non-referred cohort of healthy men and women ages 40 to 50
years.
BACKGROUND Existing studies have suggested that coronary calcium might have incremental predictive
value for coronary outcomes above standard coronary risk factors. However, additional data
from non-referred and younger populations are needed.
METHODS
Participants (n ⫽ 2,000; mean age 43 years) were evaluated with measured coronary risk
variables and coronary calcium detected with electron beam tomography. Incident acute
coronary syndromes and sudden cardiac death were ascertained via annual telephonic
contacts, with follow-up (mean, 3.0 ⫾ 1.4 years; range, 1 to 6 years) in 99.2% of the cohort.
RESULTS
Coronary calcium was found in 22.4% of men and 7.9% of women. A total of 9 acute events
occurred in men at a mean age of 46 years, including 7 of 364 men with coronary calcium
(1.95%) and 2 of 1,263 men without coronary calcium (0.16%; p ⬍ 0.0001 by log-rank). No
events occurred in women. In these men, coronary calcium was associated with an 11.8-fold
increased risk for incident coronary heart disease (CHD) (p ⫽ 0.002) in a Cox model
controlling for the Framingham risk score. Among those with coronary artery calcification,
the risk of coronary events increased incrementally across tertiles of coronary calcium severity
(hazard ratio 4.3 per tertile). A family history of premature CHD was also predictive of
incident events. The marginal cost effectiveness, assuming a 30% improvement in survival
associated with primary prevention among at-risk men, was modeled to be $37,633 per
quality-adjusted life year saved.
CONCLUSIONS In young, asymptomatic men, the presence of coronary artery calcification provides substantial, cost-effective, independent prognostic value in predicting incident CHD that is
incremental to measured coronary risk factors. (J Am Coll Cardiol 2005;46:807–14)
© 2005 by the American College of Cardiology Foundation
OBJECTIVES

Recent guidelines have highlighted the potential use of
anatomically based coronary heart disease (CHD) risk
assessments to refine the risk prediction provided through
global risk assessment tools such as the Framingham risk
score (FRS) (1– 4). One such approach uses computed
tomography (CT) to detect coronary artery calcium (CAC),
a finding that is clearly related to an increased risk of
incident CHD (5,6). However, controversy remains regarding whether, and to what extent, detection of CAC provides
incremental risk prediction beyond conventional coronary
risk factors. With the exception of the South Bay Heart
Watch (7), studies examining the relationship between
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coronary risk factors, coronary calcium, and outcomes have
used self-reported risk factor data (8 –11), introducing a
potential source of error and bias in the analyses (10,12).
The Prospective Army Coronary Calcium (PACC)
project is a prospective cohort study of U.S. Army personnel
examining the incremental prognostic value of CAC beyond
the FRS for the determination of CHD prognosis. Initiated
in 1998, we enrolled healthy asymptomatic men and women
between the ages of 40 and 50 years who were presenting for
a periodic physical examination. Herein, we report the
relationship between CAC and CHD outcomes of myocardial infarction, hospitalized unstable angina, and sudden
cardiac death based on mean three-year follow-up of the
PACC project cohort.

METHODS
This protocol was approved by the Department of Clinical
Investigation of Walter Reed Army Medical Center and
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Abbreviations and Acronyms
BMI ⫽ body mass index
CAC ⫽ coronary artery calcium
CHD ⫽ coronary heart disease
CT
⫽ computed tomography
EBCT ⫽ electron beam computed tomography
FRS ⫽ Framingham risk score
HDL ⫽ high-density lipoprotein
LDL ⫽ low-density lipoprotein
PACC ⫽ Prospective Army Coronary Calcium
QALY ⫽ quality-adjusted life years

funded under the Congressionally directed, peer-reviewed
medical research program of the Department of Defense.
The methods of the PACC project have been previously
published (13). Briefly, all active-duty Army personnel, ages
40 to 50 years old and stationed within the National Capital
Area of the Walter Reed Health Care System, were recruited at the time of a periodic, Army-mandated physical
examination. Individuals with a history of CHD or who
indicated a history of angina pectoris by the Rose questionnaire (14) were ineligible. Between October 26, 1998, and
February 19, 2003, 2,259 eligible individuals were screened
and 2,000 men and women provided written informed
consent to undergo electron beam computed tomography
(EBCT) and the cardiovascular risk-screening program.
One male participant failed to complete the coronary CT
scan, leaving 1,999 participants for analysis.
PACC Project procedures. Participants provided details
of their medical history, lifestyle behaviors, and psychosocial
history. Ethnicity was self-reported. Medical history included a history of hypertension, diabetes mellitus, hypercholesterolemia, and current medications. Smoking was
self-reported as current, recent (within six months) or
remote (more than six months ago) use of any inhaled
tobacco products, except for intermittent cigar consumption. A family history of CHD included a history of sudden
death, myocardial infarction, or coronary revascularization
in a relative before the age of 55 (males) or 65 (females)
years (15). Family history data were collected separately for
first- (parents, siblings) or second-degree (grandparents,
aunts, uncles, cousins) relatives.
Resting blood pressure was measured using an automated
sphygmomanometer, and was recorded as the average of
three seated measurements taken 5 min apart. Hypertension
was defined as either a systolic blood pressure of ⬎135 mm
Hg, a diastolic blood pressure of ⬎85 mm Hg (16), or a
history of hypertension (treated or untreated). Height and
weight were measured, and body mass index (BMI) was
calculated as weight/height2 (kg/m2). Waist girth was measured as the maximum abdominal circumference between
the iliac crest and umbilicus. The metabolic syndrome was
classified according to the recommendations of the National
Cholesterol Education Program (15). Fasting blood was
collected for the measurement of total cholesterol, low-
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density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, serum glucose,
hemoglobin A1C, lipoprotein(a), homocysteine, fibrinogen,
and insulin. Measurement of serum C-reactive protein was
added during the course of the study. The predicted 10-year
FRS for incident CHD was calculated using measured risk
factor variables as specified within regression equations from
the Framingham Heart Study (17).
The baseline coronary risk factors and their relationships
to CAC in the PACC project have been previously reported
(10,18,19). Variables having significant univariate relationships with CAC included gender, Caucasian race, hypertension, a family history of CHD, and metabolic syndrome.
Participants with CAC also had significantly higher 10-year
FRS for CHD, BMI, waist girth, blood pressure (both
systolic and diastolic), total cholesterol, LDL cholesterol,
triglycerides, and fasting glucose, and lower HDL cholesterol. All measured emerging cardiovascular risk factors
(e.g., lipoprotein(a), homocysteine, fibrinogen, serum insulin, and C-reactive protein) were unrelated to CAC.
EBCT scanning and analysis. For the measurement of
CAC, EBCT was performed using an Imatron C-150 LXP
scanner (Imatron Corp., South San Francisco, California)
calibrated daily with air and water phantoms and twicemonthly with contrast and resolution phantoms. Images
were obtained using a 40- to 50-slice (3 mm thickness)
protocol with image acquisition triggered to 60% to 80% of
the electrocardiographic RR interval while respirations were
held. Scans were interpreted in a blinded manner by an
experienced radiologist (I. M. F.) using the Agatston
scoring method (20). A focus of coronary calcium was
defined as the presence of four or more contiguous pixels
with ⬎130 Hounsfield units. A total CAC score was
determined from the sum of individual scores of the four
major epicardial coronary arteries. A scan was considered
positive for CAC when the total CAC score was ⬎0
(18,21).
CHD outcomes. The published analysis plan of the
PACC project pre-specified an actuarial five-year analysis of
the relationship between CAC and CHD events (13). To
achieve this, the vital status of the cohort was tracked
through annual telephonic contacts during which a structured interview was conducted. Detailed interviews on a
reported possible CHD event were conducted by experienced nurse coordinators who obtained details and requested source documents (hospital records) for review.
Records of the CHD event were independently reviewed by
two researchers and a third independent cardiologist to
confirm the nature of the CHD event. These reviews were
conducted blinded to all cardiovascular risk factor and CAC
data. This analysis reports adjudicated acute CHD events
defined as sudden cardiac death (sudden, unexpected death
within one hour of the onset of symptoms), myocardial
infarction (documented by elevated cardiac biomarkers and
a clinical course of care consistent with this diagnosis), and
unstable angina pectoris (acute-care hospitalization for new-
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onset or rapidly progressive chest pain or another ischemic
equivalent symptom with demonstrated inducible ischemia
or obstructive coronary artery disease and a course of care
consistent with this diagnosis). Stable chest pain syndromes
and asymptomatic revascularization procedures (one asymptomatic patient underwent percutaneous coronary revascularization after a strongly positive screening stress test) were
not included.
As of October 26, 2004, 1,983 of the 1,999 participants
with coronary CT scans remained in the study, and their
vital status was determined using direct telephonic contact
(99.2% follow-up). The mean follow-up duration was 3.0 ⫾
1.4 years. Among the 16 participants not included in this
analysis, 5 were known to be alive and well, but withdrew
consent for continued participation before their first scheduled follow-up. One died in the Pentagon terrorist attack of
September 11, 2001. Ten participants were lost to followup, although none were identified in a search of the social
security death index or were known to have accessed the
military or civilian health care network (ascertained through
military administrative health care databases) under a cardiovascular diagnosis or procedure code. These patients
were not included in the present analysis.
Statistical analysis. The primary analysis was on the relationship between CHD events and CAC. For univariate
analyses, continuous variables were compared using a t test
for independent groups and categorical variables were compared using the chi-square test. Multivariate analysis was
performed using Cox proportional hazards modeling and
stepwise methods to examine the independent predictive
value of CAC for CHD events. This analysis was conducted
for men only because no women experienced a CHD event
during follow-up. Two models were established: model I
examined how the presence of CAC predicted CHD, and
model II further investigated how the incremental severity
of CAC predicted CHD. Model II was limited to those
participants with any detectable CAC, with CAC coded in
tertiles by CAC score. Both forward and backward stepwise
methods were used to examine the unique predictive value
of CAC. In forward stepwise models, only variables that
significantly predicted CHD events (p ⬍ 0.05) were selected and entered into the equation. In backward stepwise
methods, all variables were selected and entered into the
equation first, and then removed in each step beginning
with the smallest chi-square value until the remaining
variables significantly predicted the CHD event. Participants were censored from models after the last follow-up
contact. Because of the small number of CHD outcomes,
the FRS was the only covariate in a parsimonious model. An
exploratory analysis evaluating both the FRS and a family
history of premature CHD was also conducted. Family
history was categorized as absent (no family history; 68%),
and either a first- or second-degree or both first- and
second-degree family history (32%), because both have been
reported to have predictive value in younger patient populations (22). Models incorporating a more traditional defi-
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nition (15) of premature family history restricted to firstdegree relatives of those with CHD were also evaluated and
showed similar but non-significant trends (data not shown).
Twenty participants (none with a CHD outcome) with
missing data for family history were excluded from the
models in which either first- or second-degree or both
degrees of family history was used as a predictor. Cox
regression results were expressed as hazard ratios and
reported with 95% confidence intervals. Hazard ratios for
the FRS are presented per 1% increase in 10-year risk. All
analyses were performed by an expert statistician (F.C.)
using SPSS for Windows (version 12.0, SPSS Inc., Chicago, Illinois). To extend the pre-study sample size calculations as previously published (13), a post-hoc sample size
analysis was performed using Sample Power (version 2.0,
SPSS Inc.). Data are presented as mean ⫾ standard deviation. A two-tailed p value of p ⱕ 0.05 was considered
significant.
Cost effectiveness analysis. We previously published a
decision analysis assessing the theoretical cost effectiveness
of atherosclerosis imaging in a low-risk population (23).
Using the current CHD outcomes analysis, we updated the
cost effectiveness analysis using the same decision tree and
incorporated the actual relative risk estimates observed,
using the 95% confidence limits in the sensitivity analysis.
In the model we used Bayesian logic to incorporate EBCT
into risk prediction, multiplying the adjusted predicted risk
determined by the FRS by the adjusted relative risk increase
conferred by the CAC score. In other words, the presence of
CAC multiplied the absolute risk by the adjusted relative
risk associated with CAC from this analysis. A CAC score
of zero was the referent value. We defined “at risk” as having
a calculated CHD risk using the FRS of ⱖ1% per year. This
cutoff was chosen because primary prevention has been
proven to be cost effective principally when risk exceeds this
threshold. The base case assumptions and their derivation
sources are included in detail in the prior publication
(23). In brief, the annual costs for medications if “at risk”
was $400; the utility of being “at risk” was 0.98; the
efficacy of primary prevention therapy for “at-risk” individuals was to extend life expectancy by 1.5 years among
“at-risk” patients who would live an average of 5 years less
than a cohort not “at risk”—in other words, primary
prevention would be associated with a 30% relative risk
reduction in overall mortality among an at-risk 40-yearold screening population.

RESULTS
The demographic and descriptive characteristics of the
1,983 participants are shown in Table 1, grouped separately
by gender. Caucasians were the majority of the cohort. The
group was predominately well-educated. For men, the most
prevalent cardiac risk factors were hypertension (30.8%) and
either a first- or second-degree (31.7%) family history of
CHD. The metabolic syndrome was present in 6.6%, and
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Table 1. Characteristics of the Study Participants Included in
This Report*
Variable
Age (yrs, mean ⫾ SD)
Caucasian race
African American race
College-educated
Cardiac risk factors
Hypertension
1st-degree family history of CHD
Either 1st- or 2nd-degree or both
degrees of family history for CHD
Metabolic syndrome
Current tobacco use
Diabetes mellitus
10-yr Framingham risk index, CHD
10-yr Framingham risk index, CVD
Coronary artery calcification score
Mean
Median
CAC score ⫽ 0
CAC score ⫽ 1–9
CAC score ⫽ 10–44
CAC score ⱖ45
Baecke Sports index†
Body mass index (kg/m2)
Waist girth (cm)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Total cholesterol (mg/dl)
LDL cholesterol (mg/dl)
HDL cholesterol (mg/dl)
Triglycerides (mg/dl)
Fasting glucose (mg/dl)
Hemoglobin A1C (%) (n ⫽ 1,581)
Lipoprotein(a) (mg/dl)
Homocysteine (mol/l)
Fibrinogen (mg/dl)
Insulin (U/ml)
C-reactive protein (mg/l)‡

Men
(n ⴝ 1,627)

Women
(n ⴝ 356)

42.9 ⫾ 2.8
71.8%
17.8%
82.6%

42.8 ⫾ 2.7
56.2%
30.6%
75%

30.8%
18.5%
31.7%

19.1%
20.4%
31.5%

6.6%
6.9%
0.8%
4.6 ⫾ 2.6
7.3 ⫾ 3.9

3.7%
11.2%
0%
1.4 ⫾ 1.2
3.2 ⫾ 2.5

19.5 ⫾ 110.7
0
1,263 (77.6%)
120 (7.4%)
120 (7.4%)
124 (7.6%)
3.0 ⫾ 1.0
27.8 ⫾ 3.5
95.8 ⫾ 24.9
124.3 ⫾ 12.0
77.6 ⫾ 8.8
204.2 ⫾ 36.1
128.5 ⫾ 31.4
50.4 ⫾ 12.62
129.8 ⫾ 86.5
92.7 ⫾ 11.1
5.4 ⫾ 0.6
30.1 ⫾ 33.5
9.6 ⫾ 2.5
315.2 ⫾ 58.9
8.0 ⫾ 6.0
1.9 ⫾ 2.2

3.3 ⫾ 20.0
0
328 (92.1%)
11 (3.1%)
8 (2.2%)
9 (2.5%)
2.6 ⫾ 1.2
25.9 ⫾ 3.7
82.3 ⫾ 10.1
115.5 ⫾ 13.4
72.3 ⫾ 9.1
195.8 ⫾ 34.9
112.1 ⫾ 30.0
65.03 ⫾ 16.10
88.6 ⫾ 51.2
87.4 ⫾ 8.9
5.3 ⫾ 0.4
38.1 ⫾ 41.3
8.0 ⫾ 3.6
337.8 ⫾ 65.5
8.2 ⫾ 4.9
2.4 ⫾ 2.5

*Mean ⫾ standard deviation; †Baecke Sports index score ranges from 1 to 5, 5 being
most active; ‡C-reactive protein, n ⫽ 832 (men) and 184 (women).
CAC ⫽ coronary artery calcium; CHD ⫽ coronary heart disease; CVD ⫽
cerebrovascular disease; HDL ⫽ high-density lipoprotein; LDL ⫽ low-density
lipoprotein.

p ⫽ 0.19) was similar in those with and without CHD
events. Four events occurred in men with a 10-year FRS
⬍6%, and five occurred in men with a FRS between 6% and
10%. No events occurred in the 72 men with an FRS above
10%. Five of the nine events occurred in men with either a
first- or second-degree family history of premature CHD (n
⫽ 505).
The CHD events occurred in 7 of 364 men with CAC
(1.95%) and 2 of 1,263 without CAC (0.16%; p ⬍ 0.0001
by log-rank) (Table 2, Fig. 1). Cox regression showed that
the presence of any CAC was associated with an 11.8-fold
increased risk for acute CHD (p ⫽ 0.002) after controlling
for the FRS (Table 3). Among those men with CAC
present, the risk of CHD related to increasing severity of
CAC was found to be incremental across CAC tertiles
(hazard ratio, 4.3 per quartile; p ⫽ 0.036) after controlling
for the FRS (Table 4, Fig. 2). These significant relationships between CAC and CHD outcomes were marginally
weaker in exploratory models controlling for both the FRS
and a family history of premature CHD (Tables 3 and 4 for
model II). A post-hoc sample size analysis indicated that,
using the observed prevalence of CAC, hazard rates for
CHD outcomes, and time frame of this study, a total sample
of 1,200 patients had an 80% power to find a statistically
significant result. The actual power of this study was 91%.
Cost effectiveness analysis. Using the adjusted relative risk
associated with having CAC in this cohort with its associated
95% confidence interval, the marginal cost effectiveness of
incorporating EBCT into a conventional risk prediction assessment was projected to be $37,633/quality-adjusted life year
(QALY), ranging from $31,500/QALY using the upper adjusted relative risk limit estimate of 60, to $500,000/QALY
using the lower adjusted relative risk limit estimate of 2 (Fig.
3). This was sensitive to the efficacy of primary prevention at
Table 2. The Distribution of CHD Events by Coronary
Calcium, Framingham Risk Score Categories, and Family
History of CHD
CHD Events
Variable

6.9% of participants were active tobacco users. The mean
10-year FRS for CHD was 4.6 ⫾ 2.7%. Coronary artery
calcification was detected in 22.4% of male participants,
with a mean CAC score of 20 ⫾ 111. Coronary artery
calcification was detected in 7.9% of female participants,
with a mean CAC score of 3 ⫾ 20. Among the 4.4% (72 of
1,627) of the male study cohort with a 10-year FRS ⱖ 10%,
24 had CAC. Thus, a total of 412 patients had either
elevated FRS (ⱖ10%) or CAC present.
During the follow-up period (mean, 3.0 ⫾ 1.4 years;
range, 1 to 6 years), there were nine acute CHD events
(definite myocardial infarction, unstable angina, or CHD
death). All of these events occurred in men, with a mean age
of 43 years. Among these men, the mean age at the time of
the event (46 ⫾ 2 years [at time of event] vs. 46 ⫾ 3 years
[at last follow-up]) and FRS (5.7 ⫾ 2.6% vs. 4.6 ⫾ 1.9%;

Coronary calcium
Present
Absent
Coronary calcium score tertiles
CAC score ⫽ 1–9
CAC score ⫽ 10–44
CAC score ⱖ45
Framingham risk score
⬍6%
6%–10%
⬎10%
Family history of CHD
No family history
With either 1st- or 2nd-degree
family history
With both 1st- and 2nd-degree
family history
Abbreviations as in Table 1.

Yes

No

n

7
2

357
1,261

364
1,263

0
2
5

120
118
119

120
120
124

4
5
0

1,233
311
72

1,237
316
72

4
2

1,093
411

1,097
413

3

94

97
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Figure 1. Hazard ratio plot for coronary heart disease (CHD) events
including death, unstable angina, and myocardial infarction for male
Prospective Army Coronary Calcium project participants with (⫺) (n ⫽
364) and without (⫹) (n ⫽ 1,263) coronary artery calcium (CAC).

improving overall survival. When the relative improvement
in overall survival associated with primary preventive measures (measures unique to at-risk populations: aspirin,
statins, lower goals for blood pressure and cholesterol) was
assumed to be 25% (Fig. 3), the marginal cost effectiveness
was ⬃$100,000/QALY (ranging from $1,000,000.00/
QALY to $79,000.00/QALY using the lower to upper
confidence interval on the RR estimates); when the efficacy
of primary prevention was assumed to be a 45% relative
improvement in survival, the marginal cost effectiveness was
⬃$13,000.00/QALY (ranging from $22,000/QALY to
$11,500/QALY).

DISCUSSION
The results of this pre-specified, mid-term analysis of the
PACC project support the presence of a strong, independent relationship between CAC and premature, incident
CHD in men. This finding, from a cohort of non-referred
study participants with measured cardiovascular risk vari-

ables and complete follow-up, persisted after controlling for
the FRS, thereby supporting the concept that CAC screening is an incremental tool in the identification of individuals
at increased risk for CHD.
Many studies have examined the relationship between
CAC, coronary risk factors, and CHD events (7–11,24,25).
Although each of these studies has reported an independent
relationship between CAC and either mortality or CHD
events, there is a substantial degree of variability in the
reported strength of this relationship. A recent metaanalysis (6) concluded that three factors, including the
manner of risk factor assessment, the adjudication of outcomes, and the inclusion of women in the cohort, accounted
for most of these differences. The lowest estimate of the
incremental value of coronary CT comes from the only
study (an analysis limited to non-diabetic participants of the
South Bay Heart Watch [7]) that used measured rather than
historical risk factor data. Inaccuracy in the reporting of
historical risk factors potentially induces bias in favor of the
more accurately measured variable, CAC (8 –11,24,25).
Thus, use of measured risk factors, as in the PACC project,
is the only fully acceptable means of ascertaining the true
incremental value of CAC scanning. Outcome assessments
blinded to clinical risk factor and CAC scores are crucial to
objectively categorize the observed events. Lastly, for a given
age, women have lower FRS, lower CAC scores, and a
lower event rate (26). Thus, combining genders in any
analysis of CAC and outcomes consequently increases the
reported relative risk of higher CAC scores (observed more
commonly in men), an effect that is magnified in the
mixed-gender cohorts that are primarily male. The current
analysis of the PACC project adheres to each of these
essential study and analysis components.
Direct measurement of coronary risk factors incorporated
into a global risk scoring algorithm, such as the FRS, is a
necessary starting point in the evaluation of CHD risk.
However, the FRS incompletely identifies CHD risk (27)
and may lead to systematic overestimation of risk in lowerrisk populations. Coupled with an increasing recognition of
the low specificity (28) of defined “risk factors” as a direct
consequence of lowered thresholds in risk factors (for
example, for blood pressure and cholesterol [15]), plaque
burden assessments offer a quantitative, anatomic, disease-

Table 3. Cox Models Evaluating the Incremental Predictive Value of Coronary Calcium
Presence on the Risk of CHD Events in Men
Variable

Hazard
Ratio

p
Value

Model I: controlling for Framingham risk score only (n ⫽ 1,627)
Framingham risk score
1.10
0.37
Any CAC
11.82
0.002
Model II: controlling for Framingham risk score and family history of CHD (n ⫽ 1,607)
Framingham risk score
1.10
0.40
Family history of CHD
2.53
0.043
Any CAC
10.75
0.003
Framingham risk score per 1% absolute risk change.
Abbreviations as in Table 1.

811

95% Confidence
Interval
0.90–1.35
2.45–56.93
0.89–1.35
1.03–6.20
2.23–51.84

812
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Table 4. Cox Models Evaluating the Incremental Value of Coronary Calcium Severity on the
Risk of CHD Events in Men With Coronary Calcium Present
Variable

Hazard
Ratio

p
Value

95% Confidence
Interval

Model I: controlling for Framingham risk score only (n ⫽ 364)
Framingham risk score
1.06
0.67
Tertile CAC
4.32
0.036
Model II: controlling for Framingham risk score and family history of CHD (n ⫽ 357)
Framingham risk score
1.09
0.51
Family history of CHD
4.23
0.013
Tertile CAC
4.80
0.034

0.81–1.38
1.10–16.97
0.84–1.42
1.36–13.13
1.13–20.44

Framingham risk score per 1% absolute risk change. Tertile analysis is referent to tertile 1—CAC score 1–9.
Abbreviations as in Table 1.

based method of refining the clinical assessment of CHD
risk. Consistent with this, the assessment of CAC in
primarily intermediate-risk individuals has been advocated
in several recent guidelines and position statements (1–3).
The PACC project data support this general concept and
challenge the notion that plaque burden assessments should
not be applied to younger populations at lower absolute
CHD risk. Potential advantages of screening individuals 40
to 50 years of age include the generally lower prevalence of
CAC limiting the potential for overidentification of individuals identified as at risk because of the dominant relationship between age and CAC. Furthermore, effective
therapies arising out of such a screening approach can
include lifestyle modifications through a case management
approach (29) and low-cost effective pharmacotherapies
such as aspirin and generic statins.
Concerns about cost effectiveness are critically important.
As our revised cost effectiveness analysis suggests, a screen-

Figure 2. Hazard ratio plot for coronary heart disease (CHD) events
including death, unstable angina, and myocardial infarction for male
Prospective Army Coronary Calcium project participants with coronary
calcium (n ⫽ 364) categorized into calcium score tertiles. CCS ⫽ coronary
calcium score.

ing approach including a global risk assessment tool and
coronary calcium imaging for CHD risk detection is relatively cost effective even when considered across long time
horizons of modestly effective preventive therapies. Importantly, cost effectiveness is highly dependent on the efficacy
of primary CHD prevention. This implies that, after the
identification of increased CHD risk, full application of,
and adherence to, preventative measures becomes critical.
However, because of the low event rate in the overall
population, even among those with CAC, unnecessary
testing should be avoided. Thus, criteria should be sought
for the optimal selection of low-risk individuals with the
greatest likelihood of benefit from CAC screening.
Study limitations. The data within this study are generalizable to healthy, physically active individuals from whom
the U. S. Army recruits volunteers. Prior studies in this
population have confirmed the generalizability of data from
U.S. Army cohorts. As expected, based on the younger age
of the study population, the CHD event rate was low.
Notable, however, is that these individuals all suffered
premature CHD events at a mean age of 46 years. Furthermore, it is notable that the actuarial event risk in those men
with CAC in this pre-specified analysis was approximately
1% per year overall, with a demonstrable gradient of risk
observed across higher CAC scores. Low event rates do

Figure 3. Three-dimensional bar graph showing the interaction of the
relative risk reduction (RRR) of coronary interventions and the total
proportion of the screened population to be considered as at risk (using
both the Framingham risk score [FRS] and coronary calcium testing
together) on cost effectiveness (quality-adjusted life years [QALY]). The
yellow bar indicates the base case for the Prospective Army Coronary
Calcium project. CAC ⫽ coronary artery calcium.
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diminish the ability to control for additional covariates
beyond the FRS, and also diminish the precision of our risk
estimates.
The present analysis is underpowered to exclude a relationship between CAC and CHD events in women. Data
from Raggi et al. (26) indicate that such a relationship does
exist with respect to total mortality, but further study in
large female cohorts is needed, specifically with respect to
cardiovascular-specific outcomes.
Sensitivity analysis on the effect of the estimated relative
risk on cost effectiveness of screening suggests that a strategy
of adding CAC to global coronary risk assessments would
be cost effective across a broad range of relative risk
associated with CAC. The cost effectiveness of screening for
CAC is sensitive to the efficacy of primary prevention
interventions (e.g., lifestyle and medications) in prolonging
quality-adjusted survival. The Multiple Risk Factor Intervention Trial did show an 8% relative risk reduction at 10.5
years in overall mortality during an era of less effective risk
factor interventions (30). Thus we feel that it is reasonable
to assume that there may be at least a 30% relative risk
reduction for primary prevention strategies among higherrisk individuals over a 30- to 40-year lifetime horizon.
However, this is unproven.

5.

6.

7.

8.

9.

10.

11.

12.

13.

CONCLUSIONS
Although further studies including women and ethnic
minorities are needed to extend these data, the PACC
project, including the use of measured coronary risk factors
and complete follow-up data, has shown the incremental
predictive value of CAC over conventional risk factors for
premature CHD outcomes. Beyond this demonstration of
incremental prognostic value, important questions such as
those of effectiveness and cost effectiveness remain. Although these questions are best answered through dedicated
prospective clinical trials, the costs, ethics, and feasibility of
such trials are formidable obstacles to their completion.
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